Search Results

There are 10370 results for: content related to: Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma

  1. You have full text access to this OnlineOpen article
    Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer

    Cancer Science

    Volume 108, Issue 3, March 2017, Pages: 455–460, Yuka Inoue, Shoichi Hazama, Nobuaki Suzuki, Yukio Tokumitsu, Shinsuke Kanekiyo, Shinobu Tomochika, Ryouichi Tsunedomi, Yoshihiro Tokuhisa, Michihisa Iida, Kazuhiko Sakamoto, Shigeru Takeda, Tomio Ueno, Shigefumi Yoshino and Hiroaki Nagano

    Version of Record online : 3 APR 2017, DOI: 10.1111/cas.13162

  2. You have full text access to this Open Access content
    Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy

    Cancer Science

    Volume 103, Issue 4, April 2012, Pages: 791–796, Yao-Yu Hsieh, Cheng-Hwai Tzeng, Ming-Huang Chen, Po-Min Chen and Wei-Shu Wang

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1349-7006.2012.02225.x

  3. You have full text access to this OnlineOpen article
    Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer

    Cancer Science

    Volume 107, Issue 4, April 2016, Pages: 514–520, Ryoichi Miyamoto, Tatsuya Oda, Shinji Hashimoto, Tomohiro Kurokawa, Yuki Inagaki, Osamu Shimomura, Yusuke Ohara, Keiichi Yamada, Yoshimasa Akashi, Tsuyoshi Enomoto, Mikio Kishimoto, Hideto Yanagihara, Eiji Kita and Nobuhiro Ohkohchi

    Version of Record online : 4 MAR 2016, DOI: 10.1111/cas.12888

  4. You have full text access to this Open Access content
    Ligand-triggered resistance to molecular targeted drugs in lung cancer: Roles of hepatocyte growth factor and epidermal growth factor receptor ligands

    Cancer Science

    Volume 103, Issue 7, July 2012, Pages: 1189–1194, Seiji Yano, Shinji Takeuchi, Takayuki Nakagawa and Tadaaki Yamada

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1349-7006.2012.02279.x

  5. You have full text access to this OnlineOpen article
    Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

    Cancer Science

    Volume 105, Issue 8, August 2014, Pages: 996–1001, Gerald W. Prager, Kira H. Braemswig, Alexandra Martel, Matthias Unseld, Georg Heinze, Thomas Brodowicz, Werner Scheithauer, Gabriela Kornek and Christoph C. Zielinski

    Version of Record online : 31 JUL 2014, DOI: 10.1111/cas.12451

  6. You have full text access to this Open Access content
    Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody

    Cancer Science

    Volume 104, Issue 10, October 2013, Pages: 1330–1338, Feng Wen, Ruilei Tang, Yaxiong Sang, Meng Li, Qiancheng Hu, Zedong Du, Yi Zhou, Pengfei Zhang, Xiaofeng He and Qiu Li

    Version of Record online : 30 JUL 2013, DOI: 10.1111/cas.12224

  7. You have full text access to this Open Access content
    Second-line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild-type KRAS

    Cancer Science

    Volume 104, Issue 4, April 2013, Pages: 473–480, Yong Sang Hong, Hwa Jung Kim, Seong Joon Park, Kyu-Pyo Kim, Jae-Lyun Lee, Jin Hong Park, Jong Hoon Kim, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim, Ji Yeon Baek, Sun Young Kim and Tae Won Kim

    Version of Record online : 14 FEB 2013, DOI: 10.1111/cas.12098

  8. You have full text access to this Open Access content
    Estrogen receptor α and β in esophageal squamous cell carcinoma

    Cancer Science

    Volume 103, Issue 7, July 2012, Pages: 1348–1355, Masashi Zuguchi, Yasuhiro Miki, Yoshiaki Onodera, Fumiyoshi Fujishima, Daisuke Takeyama, Hiroshi Okamoto, Go Miyata, Akira Sato, Susumu Satomi and Hironobu Sasano

    Version of Record online : 15 MAY 2012, DOI: 10.1111/j.1349-7006.2012.02288.x

  9. You have full text access to this OnlineOpen article
    Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors

    Cancer Science

    Volume 108, Issue 1, January 2017, Pages: 53–60, Hirokazu Taniguchi, Shinji Takeuchi, Koji Fukuda, Takayuki Nakagawa, Sachiko Arai, Shigeki Nanjo, Tadaaki Yamada, Hiroyuki Yamaguchi, Hiroshi Mukae and Seiji Yano

    Version of Record online : 30 DEC 2016, DOI: 10.1111/cas.13111

  10. You have full text access to this Open Access content
    Molecular biology of chronic myeloid leukemia

    Cancer Science

    Volume 103, Issue 9, September 2012, Pages: 1601–1610, Yoshiro Maru

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1349-7006.2012.02346.x

  11. You have full text access to this Open Access content
    Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer

    Cancer Science

    Volume 103, Issue 9, September 2012, Pages: 1617–1624, Koji Okabayashi, Tomonobu Fujita, Junichiro Miyazaki, Tsutomu Okada, Takashi Iwata, Nobumaru Hirao, Shinobu Noji, Nobuo Tsukamoto, Naoki Goshima, Hirotoshi Hasegawa, Hiroya Takeuchi, Masakazu Ueda, Yuko Kitagawa and Yutaka Kawakami

    Version of Record online : 16 JUL 2012, DOI: 10.1111/j.1349-7006.2012.02355.x

  12. You have full text access to this Open Access content
    Novel regulation of checkpoint kinase 1: Is checkpoint kinase 1 a good candidate for anti-cancer therapy?

    Cancer Science

    Volume 103, Issue 7, July 2012, Pages: 1195–1200, Hidemasa Goto, Ichiro Izawa, Ping Li and Masaki Inagaki

    Version of Record online : 23 APR 2012, DOI: 10.1111/j.1349-7006.2012.02280.x

  13. You have full text access to this Open Access content
    Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir, India

    Cancer Science

    Volume 104, Issue 9, September 2013, Pages: 1231–1236, Nazir A. Dar, Idrees A. Shah, Gulzar A. Bhat, Muzamil A. Makhdoomi, Beenish Iqbal, Rumaisa Rafiq, Iqra Nisar, Arshid B. Bhat, Sumaiya Nabi, Akbar Masood, Sajad A. Shah, Mohd M. Lone, Showkat A. Zargar, Farhad Islami and Paolo Boffetta

    Version of Record online : 1 JUL 2013, DOI: 10.1111/cas.12210

  14. You have full text access to this Open Access content
    Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma

    Cancer Science

    Volume 103, Issue 8, August 2012, Pages: 1586–1594, Xiang-Bo Wan, Xin-Juan Fan, Pei-Yu Huang, Dong Dong, Yan Zhang, Ming-Yuan Chen, Jin Xiang, Jie Xu, Li Liu, Wei-Hua Zhou, Yan-Chun Lv, Xiang-Yuan Wu, Ming-Huang Hong and Quentin Liu

    Version of Record online : 5 JUL 2012, DOI: 10.1111/j.1349-7006.2012.02332.x

  15. You have full text access to this Open Access content
    Differences and similarities between carbon nanotubes and asbestos fibers during mesothelial carcinogenesis: Shedding light on fiber entry mechanism

    Cancer Science

    Volume 103, Issue 8, August 2012, Pages: 1378–1390, Hirotaka Nagai and Shinya Toyokuni

    Version of Record online : 14 JUN 2012, DOI: 10.1111/j.1349-7006.2012.02326.x

  16. You have full text access to this Open Access content
    Hepatocellular carcinoma: Towards personalized medicine

    Cancer Science

    Volume 103, Issue 5, May 2012, Pages: 846–850, Daiki Miki, Hidenori Ochi, C. Nelson Hayes, Hiroshi Aikata and Kazuaki Chayama

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1349-7006.2012.02242.x

  17. You have full text access to this Open Access content
    Significance of epithelial growth factor in the epithelial–mesenchymal transition of human gallbladder cancer cells

    Cancer Science

    Volume 103, Issue 6, June 2012, Pages: 1165–1171, Takamitsu Sasaki, Hiroki Kuniyasu, Yi Luo, Daisuke Kato, Satoshi Shinya, Kiyomu Fujii, Hitoshi Ohmori and Yuichi Yamashita

    Version of Record online : 3 APR 2012, DOI: 10.1111/j.1349-7006.2012.02264.x

  18. You have full text access to this Open Access content
    Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy

    Cancer Science

    Volume 104, Issue 11, November 2013, Pages: 1401–1410, Miao Ding, Erlong Zhang, Rong He and Xingyong Wang

    Version of Record online : 23 SEP 2013, DOI: 10.1111/cas.12252

  19. You have full text access to this OnlineOpen article
    Targeting DNA damage response in cancer therapy

    Cancer Science

    Volume 105, Issue 4, April 2014, Pages: 370–388, Noriko Hosoya and Kiyoshi Miyagawa

    Version of Record online : 21 MAR 2014, DOI: 10.1111/cas.12366

  20. You have full text access to this Open Access content
    Prostate cancer genomics, biology, and risk assessment through genome-wide association studies

    Cancer Science

    Volume 103, Issue 4, April 2012, Pages: 607–613, Hidewaki Nakagawa, Shusuke Akamatsu, Ryo Takata, Atsushi Takahashi, Michiaki Kubo and Yusuke Nakamura

    Version of Record online : 29 JAN 2012, DOI: 10.1111/j.1349-7006.2011.02193.x